Skip to main content
SpringerLink
Log in

Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background:Cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis is used as a palliative treatment for a variety of malignancies. The purpose of this study was to measure the quality of life (QOL) of survivors (>3 years) after treatment.

Methods:Patients were interviewed by telephone with the following tools: (1) the Functional Assessment of Cancer Therapy–Colon (FACT-C), (2) the Short Form of the Medical Outcomes Study Questionnaire, (3) the Center for Epidemiologic Studies–Depression scale, (4) the Life Appreciation scale, (5) the Psychosocial Concerns Questionnaire, and (6) performance status rating.

Results:Seventeen (10 appendix, 5 large intestine, 1 ovarian, and 1 peritoneum) of 109 patients were interviewed from 3.1 to 8.0 years after treatment. Ten patients (62.5%) described their health as excellent or very good. No limitations on moderate activity were reported in 94% of cases. Paired t-tests were used to compare 10 patients who had baseline QOL data. FACT mean difference scores and P values (positive difference scores indicate improved QOL) were functional well-being: 4.9, P = .01; physical well-being: 3.3, P = .05; and FACT total: 14.3, P = .02.

Conclusions:Long-term survival with good QOL is possible for selected patients with peritoneal carcinomatosis after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Spratt JS, Edwards E, Kubata T, Lineberg R, Tseng MT. Peritoneal carcinomatosis: anatomy, physiology, diagnosis, management. Curr Probl Cancer 1986; 10: 555–84.

    Google Scholar 

  2. Sugarbaker PH. Peritoneal Carcinomatosis. Drugs and Diseases. Boston: Kluwer, 1996.

  3. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364–7.

    PubMed  CAS  Google Scholar 

  4. Marcus EA, Weber TK, Rodriguez-Bigas MA, Driscoll D, Meropol NJ, Petrelli NJ. Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest 1999; 17: 249–52.

    Article  PubMed  CAS  Google Scholar 

  5. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358–63.

    PubMed  CAS  Google Scholar 

  6. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000; 66: 561–8.

    CAS  PubMed  Google Scholar 

  7. McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001; 27: 65–73.

    Article  CAS  PubMed  Google Scholar 

  8. McQuellon RP, Russell GB, Rambo TD, et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 1998; 21: 477–86.

    PubMed  CAS  Google Scholar 

  9. McQuellon RP, Muss HB, Hoffman SL, Russell G, Craven B, Yellen SB. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer. J Clin Oncol 1995; 13: 858–68.

    PubMed  CAS  Google Scholar 

  10. McQuellon RP, Muss HB, Hoffman S, et al. The influence of treatment toxicity on treatment preferences of women with breast cancer. Proc Am Soc Clin Oncol 1994; 13: 76.

    Google Scholar 

  11. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570–9.

    CAS  PubMed  Google Scholar 

  12. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston: Nimrod Press, 1993.

  13. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40–66.

    CAS  PubMed  Google Scholar 

  14. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–63.

    CAS  PubMed  Google Scholar 

  15. Radloff LS, Teri L. Use of the Center for Epidemiological Studies-Depression Scale with older adults. Clin Gerontol 1986; 5: 119–36.

    Google Scholar 

  16. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.

    Google Scholar 

  17. Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960; 11: 7–33.

    Article  Google Scholar 

  18. Andrykowski MA, Cordova MJ, Hann DM, Jacobsen PB, Fields KK, Phillips G. Patients’ psychosocial concerns following stem cell transplantation. Bone Marrow Transplant 1999; 24: 1121–9.

    PubMed  CAS  Google Scholar 

  19. McQuellon RP, Loggie BW, Russell GB, et al. Health related quality of life (QOL) before and after surgically directed intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis (PC) (abstract). Proc Am Soc Clin Oncol 1997; 16: 76a.

    Google Scholar 

  20. Andrykowski MA, Brady MJ, Hunt JW. Positive psychosocial adjustment in potential bone marrow transplant recipients: cancer as a psychosocial transition. Psycho-Oncology 1993; 2: 201–76.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, The Surgical Oncology Service, Wake Forest University School of Medicine, Winston-Salem, North Carolina

    Richard P. McQuellon PhD, Brian W. Loggie MD & Ronald A. Fleming PharmD

  2. Section of Hematology and Oncology, Public Health Sciences, The Surgical Oncology Service, Wake Forest University School of Medicine, Winston-Salem, North Carolina

    Gregory B. Russell MS

  3. Department of General Surgery, The Surgical Oncology Service, Wake Forest University School of Medicine, Winston-Salem, North Carolina

    Perry Shen MD & Edward A. Levine MD

  4. Surgical Oncology Section, Creighton University, Omaha, Nebraska

    Anna B. Lehman MA

  5. Comprehensive Cancer Center of Wake Forest University, Medical Center Blvd., Winston-Salem, NC 27157-1082

    Richard P. McQuellon PhD

Authors
  1. Richard P. McQuellon PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian W. Loggie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna B. Lehman MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregory B. Russell MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ronald A. Fleming PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Perry Shen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Edward A. Levine MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard P. McQuellon PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McQuellon, R.P., Loggie, B.W., Lehman, A.B. et al. Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis. Ann Surg Oncol 10, 155–162 (2003). https://doi.org/10.1245/ASO.2003.03.067

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.067

Key Words:

Search

Navigation